Liver TransplantationKidneyLiver DiseasesKidney TransplantationLiver FailureGraft RejectionImmunosuppressive AgentsGraft SurvivalLiver CirrhosisLiverTacrolimusLiving DonorsTissue DonorsEnd Stage Liver DiseaseLiver NeoplasmsTissue and Organ ProcurementWaiting ListsKidney DiseasesPostoperative ComplicationsTreatment OutcomeTransplantationTransplantsRetrospective StudiesTime FactorsLiver Function TestsTransplantation, HomologousCyclosporineLiver RegenerationFatty LiverMycophenolic AcidImmunosuppressionCadaverMicrosomes, LiverKidney Failure, ChronicLiver Failure, AcuteHeart TransplantationRisk FactorsCytomegalovirus InfectionsHepatitis CKidney TubulesCarcinoma, HepatocellularRecurrenceDonor SelectionFollow-Up StudiesAcute Kidney InjuryTransplantation ImmunologyHepatic ArteryDrug-Induced Liver InjuryHepatectomyKidney Function TestsPostoperative PeriodLiver CirculationPortal VeinBiliary AtresiaKidney CortexMitochondria, LiverLung TransplantationLiver Cirrhosis, AlcoholicBiliary Tract DiseasesAntiviral AgentsSurvival RateCreatinineLiver Diseases, AlcoholicSurvival AnalysisRisk AssessmentTransplantation ToleranceImmunocompromised HostProspective StudiesBiopsyIncidencePatient SelectionCalcineurinDrug Therapy, CombinationReoperationHistocompatibility TestingAlanine TransaminaseGlomerular Filtration RateFatal OutcomeKaplan-Meier EstimateCholestasisGanciclovirRenal InsufficiencyPolycystic Kidney DiseasesKidney GlomerulusBone Marrow TransplantationKidney NeoplasmsCholangitis, SclerosingBilirubinLiver Neoplasms, ExperimentalLiver ExtractsHepatopulmonary SyndromeBrain DeathDeathCytomegalovirusOpportunistic InfectionsSeverity of Illness IndexHepatic VeinsCohort StudiesLymphoproliferative DisordersSirolimus